Treatment of renal osteodystrophy

被引：1
|
作者：
Gal-Moscovici A. [1 ,2 ]
Sprague S.M. [2 ,4 ]
Lerma E.V. [3 ]
机构：
[1] Hadassah Hospital Medical Center, Hebrew University, Ein Keren, Jeruslaem
[2] Division of Nephrology and Hypertension, Evanston Northwestern Healthcare, Northwestern University Feinberg School of Medicine, Evanston, IL
[3] Section of Nephrology, University of Illinois at Chicago, College of Medicine/Associates in Nephrology, Chicago, IL
[4] Evanston, IL 60201
来源：
Clinical Reviews in Bone and Mineral Metabolism | 2007年 / 5卷 / 1期
关键词：
Cinacalcet; Parathyroidectomy; Phosphate binders; Renal osteodystrophy; Vitamin D receptor agonist;
D O I：
10.1007/BF02736669
中图分类号：
学科分类号：
摘要：
Chronic kidney disease (CKD) is accompanied by disturbances in calcium, phosphate, vitamin D, and parathyroid hormone (PTH) homeostasis known to play an important role in the pathophysiology of renal osteodystrophy. Increased cardiovascular morbidity and mortality rate among CKD patients, correlates with these disturbances in bone and mineral metabolism and underscores the nephrologist's concern about the effectiveness of the present therapeutic approach. Treatment directed to normalize the calcium/phosphate, vitamin D and PTH abnormalities may adversely affect endothelial, vascular and bone cells activity. This article discusses the therapeutic approaches focuses for renal osteodystrophy. © Copyright 2007 by Humana Press Inc. All rights of any nature whatsoever reserved.
引用
收藏
页码：27 / 38
页数：11
相关论文
共 50 条
  • [31] RENAL OSTEODYSTROPHY - PATHO-PHYSIOLOGY AND TREATMENT
    FOURNIER, A
    SEBERT, JL
    MORINIERE, P
    GREGOIRE, I
    DEFREMONT, JF
    TAHIRI, Y
    DKHISSI, H
    HORMONE RESEARCH, 1984, 20 (01) : 44 - 58
  • [32] Renal Osteodystrophy: Review of the Disease and its Treatment
    El-Kishawi, Abdullah M. W.
    El-Nahas, A. M.
    SAUDI JOURNAL OF KIDNEY DISEASES AND TRANSPLANTATION, 2006, 17 (03) : 373 - 382
  • [33] POSSIBLE ROLE FOR PROPRANOLOL IN TREATMENT OF RENAL OSTEODYSTROPHY
    CARO, JF
    BURKE, JF
    BESARAB, A
    GLENNON, JA
    LANCET, 1978, 2 (8087): : 451 - 454
  • [34] Effects of Treatment of Renal Osteodystrophy on Bone Histology
    Malluche, Hartmut H.
    Mawad, Hanna
    Monier-Faugere, Marie-Claude
    CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2008, 3 : S157 - S163
  • [35] RECOMMENDATIONS FOR TREATMENT OF RENAL OSTEODYSTROPHY IN DIALYSIS PATIENTS
    SLATOPOLSKY, E
    KIDNEY INTERNATIONAL, 1975, 7 (01) : S253 - S255
  • [36] TREATMENT OF RENAL OSTEODYSTROPHY WITH 25-HYDROXYCHOLECALCIFEROL
    DELUCA, HF
    AVIOLI, LV
    ARCHIVES OF INTERNAL MEDICINE, 1970, 126 (05) : 896 - &
  • [37] History of vitamin D treatment of renal osteodystrophy
    Morii, H
    Ishimura, E
    Inoue, T
    Tabata, T
    Morita, A
    Nishii, Y
    Fukushima, M
    AMERICAN JOURNAL OF NEPHROLOGY, 1997, 17 (3-4) : 382 - 386
  • [38] Renal osteodystrophy in dialysis patients: Diagnosis and treatment
    Fournier, A
    Oprisiu, R
    Hottelart, C
    Yverneau, PH
    Ghazali, A
    Atik, A
    Hedri, H
    Said, S
    Sechet, A
    Rasolombololona, M
    Abighanem, O
    Sarraj, A
    El Esper, N
    Moriniere, P
    Boudailliez, B
    Westeel, PF
    Achard, JM
    Pruna, A
    ARTIFICIAL ORGANS, 1998, 22 (07) : 530 - 557
  • [39] Renal osteodystrophy in children: pathogenesis, diagnosis and treatment
    Kemper, Markus J.
    van Husen, Michael
    CURRENT OPINION IN PEDIATRICS, 2014, 26 (02) : 180 - 186
  • [40] Renal Osteodystrophy
    González E.A.
    Martin K.J.
    Reviews in Endocrine and Metabolic Disorders, 2001, 2 (2) : 187 - 193
12345